About Diane Slaughter

This author has not yet filled in any details.
So far Diane Slaughter has created 1847 blog entries.
18 08, 2022

Advocacy in Action

By |2022-08-19T18:30:57-04:00August 18th, 2022|Legislation|

  AAOS Advocacy in Action Urged the Centers for Medicare & Medicaid Services to finalize an inflationary physician payment update for 2023, which would stabilize the system until Congress acts to establish a long-term solution. Requested that UnitedHealthcare reconsider its restrictive policy on minimally invasive sacroiliac joint fusion devices, which is affecting surgeons' ability to provide care.       The Bone Beat New Episode Conversations on health policy issues affecting musculoskeletal care... Unity in Orthopaedic Advocacy   AAOS is the [...]

17 08, 2022

August 17, 2022 | Today’s News

By |2022-08-19T18:30:04-04:00August 17th, 2022|Top Stories|

  Today's Top Story Study Finds Higher Incidence of Intraoperative Periprosthetic Fractures in THA Patients with Osteoporosis A retrospective study published online in The Journal of Arthroplasty found that patients with a history of osteoporosis undergoing total hip arthroplasty (THA) had an increased risk of intraoperative periprosthetic fractures while patients undergoing total knee arthroplasty (TKA) did not. Patients with osteopetrosis (534 THA and 972 TKA) were compared with matched cohorts. The primary outcomes included postoperative surgical complications, hospital [...]

15 08, 2022

August 15, 2022 | Today’s News

By |2022-08-15T19:08:35-04:00August 15th, 2022|Top Stories|

  Today's Top Story Study: Variability in All-cause Mortality Risk with Several Anti-osteoporosis Drugs after Hip Fractures A study published in the August issue of the Journal of Bone and Mineral Research found variability in all-cause mortality associated with several anti-osteoporosis regimens after hip fracture surgery. In total, 45,226 patients were included. Compared with patients who did not receive postoperative anti-osteoporosis drugs, lower all-cause mortality rates were associated with use of oral bisphosphonates, ibandronate, zoledronic acid, and denosumab. [...]

12 08, 2022

August 12, 202 Today’s News

By |2022-08-15T13:49:38-04:00August 12th, 2022|Top Stories|

  Today's Top Story Study: Conversion to Below- or Above-knee Amputation after Transmetatarsal Amputation A retrospective study published in the August 15 issue of the Journal of the AAOS ® investigated risk factors associated with mortality and conversion to below-knee amputation (BKA) or above-knee amputation (AKA) after transmetatarsal amputation (TMA). A total of 286 TMAs were reviewed for revision surgery, amputation, or mortality. Analysis indicated that women, patients aged 57 to 64 years, and patients with a history [...]

10 08, 2022

August 10, 2022 | Today’s News

By |2022-08-12T10:50:33-04:00August 10th, 2022|Top Stories|

  Today's Top Story Act Now to Nominate Future Leadership The Nominating Committee is actively soliciting nominations for individuals to serve in the following positions: Second Vice President Board Member-at-large [No Age Designation] Board Member-at-large [Under Age 45] (younger than age 45 on March 13, 2023) Nominations close on August 15. Members can review the position descriptions—including information about responsibilities, desired experience, and time commitments—as well as submit nomination(s) online. Learn more and submit your nomination…     [...]

8 08, 2022

August 8, 2022 | Today’s News

By |2022-08-09T18:32:30-04:00August 8th, 2022|Top Stories|

  Today's Top Story Study: THA Leads to Better Results after Low-energy Displaced Femoral Neck Fracture in Patients Aged >55 Years In a study published online in the Journal of Bone & Joint Surgery, patients aged 55 to 70 years who underwent total hip arthroplasty (THA) for a low-energy displaced femoral neck fracture experienced better outcomes than those who underwent closed reduction and internal fixation (IF). A total of 102 patients were randomized to either IF or THA. [...]

5 08, 2022

August 5, 2022 | Today’s News

By |2022-08-07T17:54:31-04:00August 5th, 2022|Top Stories|

  Today's Top Story Orthopaedic Advocacy Week Concludes with Ask for Members to “Get Invested” On this final day of Orthopaedic Advocacy Week, U.S. AAOS members are encouraged to invest in advocacy by joining the Orthopaedic Political Action Committee (PAC) or OrthoPAC—the only PAC dedicated solely to representing orthopaedic surgeons before Congress and ensuring they have a voice in important policy discussions. Participants of the virtual, annual event have engaged in daily activities throughout the week to raise [...]

4 08, 2022

AAOS Advocacy in Action

By |2022-08-05T13:08:21-04:00August 4th, 2022|Legislation|

  AAOS Advocacy in Action Discussed the next generation of value-based care models in a meeting with the CMS Innovation Center led by AAOS Advocacy Council Chair Douglas Lundy, MD, MBA, FAAOS. Expressed support for legislation that would allow physicians with a 90% prior authorization approval rating to be exempt from prior authorization requirements under Medicare Advantage plans.       Ongoing Event Focuses on Economic Impact of Orthopaedic Surgeons         Source: 2018 AMA Economic [...]

3 08, 2022

August 3, 2022 | Today’s News

By |2022-08-05T13:09:55-04:00August 3rd, 2022|Top Stories|

  Today's Top Story Study: Novel Multilayer-coating versus Standard TKA after 10-year Follow-up In a randomized controlled trial published in The Journal of Arthroplasty, a multilayer hypoallergenic-coated implant led to similar patient-reported outcomes (PROs) as a standard implant in total knee arthroplasty (TKA). In total, 120 patients were randomized to standard or coated TKA. Patient serum metal ion levels, knee function, quality of life, and physical activity were assessed preoperatively until 10-year follow-up. Cobalt levels increased slightly in [...]

1 08, 2022

August 1, 2022 | Today’s News

By |2022-08-02T14:48:54-04:00August 1st, 2022|Top Stories|

  Today's Top Story Orthopaedic Advocacy Week Kicks Off, Offers Simple Ways to Advance MSK Care Today marks the official start of AAOS’ second annual Orthopaedic Advocacy Week. While formal registration has closed, U.S. AAOS members can still participate in the daily virtual event activities to advocate for priority healthcare policy issues. Today, members are raising awareness across social media to capture the attention of lawmakers before sending formal letters to Congress tomorrow. Wednesday’s activity involves signing onto [...]

Go to Top